Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Abstract Background Growing evidence has demonstrated that DNA methylation (DNAm) plays an important role in Alzheimer’s disease (AD) and that DNAm differences can be detected in the blood of AD subjects. Most studies have correlated blood DNAm with the clinical diagnosis of AD in living individuals...

Full description

Bibliographic Details
Main Authors: Wei Zhang, Juan I. Young, Lissette Gomez, Michael A. Schmidt, David Lukacsovich, Achintya Varma, X. Steven Chen, Eden R. Martin, Lily Wang
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Alzheimer’s Research & Therapy
Subjects:
DNA methylation
CSF biomarkers
Alzheimer’s disease
Online Access:https://doi.org/10.1186/s13195-023-01216-7

Internet

https://doi.org/10.1186/s13195-023-01216-7

Similar Items